Table 3:
Subgroup meta-analysis of the administration route with respect to the total efficacy rate of mecobalamin in DGP
| Subgroup | Model for meta-analysis | No. of trials | Effect size (95%CI) | P-value | I2 (%) | Q-statistics (P) |
|---|---|---|---|---|---|---|
| mecobalamin im | FE | 10 | 3.54 (2.29–5.46) | <0.001 | 0 | 0.95 |
| mecobalamin po | 14 | 5.24 (3.62–7.59) | <0.001 | 0 | 0.94 |
po, oral; im, intramuscular injection; FE, fixed -effects model.